![]() | Up a level |
Davies, Mark, Saxena, Anurag and Kingswood, John C. 2017. Management of everolimus-associated adverse events in patients with tuberous sclerosis complex: a practical guide. Orphanet Journal of Rare Diseases 12 (1) 10.1186/s13023-017-0581-9 |
|
Randell, Elizabeth, McNamara, Rachel, Davies, D. Mark, Owen-Jones, Catrin, Kirby, Nigel, Angel, Lianna, Drew, Cheney, Cannings-John, Rebecca, Smalley, Michelle, Saxena, Anurag, McDermott, Emer, Stockwell, Laura, de Vries, Petrus J., Hood, Kerenza and Sampson, Julian R.
2016.
The use of everolimus in the treatment of neurocognitive problems in tuberous sclerosis (TRON): study protocol for a randomised controlled trial.
Trials
17
, 398.
10.1186/s13063-016-1446-6
![]() |
|
Sampson, Julian Roy and Saxena, Anurag 2015. Epilepsy in tuberous sclerosis: phenotypes, mechanisms, and treatments. Seminars in Neurology 35 (03) , pp. 269-276. 10.1055/s-0035-1552616 |
![]() |
Saxena, Anurag and Sampson, Julian 2014. Phenotypes associated with inherited and developmental somatic mutations in genes encoding mTOR pathway components. Seminars in Cell and Developmental Biology 36 , pp. 140-146. 10.1016/j.semcdb.2014.09.018 |
![]() |